Cardiovascular diseases are popularly known as heart diseases. These diseases are associated with circulatory system and heart. To list a few common cardiovascular diseases—rheumatic heart disease, hypertensive heart disease, inflammatory heart disease, ischemic heart disease, and cerebrovascular heart disease. High blood pressure causes hypertensive heart disease. Key concerns related to hypertensive heart disease are ... Read more
Cardiovascular disorders or heart disorders are disorders of circulatory systems and heart. Inflammatory heart disease, hypertensive heart disease, cerebrovascular heart disease, rheumatic heart disease, and ischemic heart disease fall under the commonly diagnosed cardiovascular disorders. In most cases, the occurrence of high blood pressure leads to hypertensive heart ailments. Major effects of hypertensive heart ailments include hypertrophy, angina, coronary heart disease and heart failure ... Read more
Cardiovascular diseases (CVDs) comprise disorders and conditions related to circulatory system which include heart and vascular system. The global cardiovascular drugs market was valued approximately US$ 80.0 Bn in 2016 and is anticipated to register CAGR of over 1.0% from 2017 to 2025 to reach value of approximately US$ 91.0 Bn by 2025. Drug classes used to treat cardiovascular indications such as hyperlipidemia, hypertension are likely to fuel expansion of the global cardiovascular drugs ... Read more
Cardiovascular diseases (CVDs) comprise disorders and conditions related to circulatory system which include heart and vascular system. The global cardiovascular drugs market was valued approximately US$ 80.0 Bn in 2016 and is anticipated to register CAGR of over 1.0% from 2017 to 2025 to reach value of approximately US$ 91.0 Bn by 2025. Drug classes used to treat cardiovascular indications such as hyperlipidemia, hypertension are likely to fuel expansion of the global cardiovascular drugs ... Read more
Cardiovascular diseases (CVDs) comprise disorders and conditions related to circulatory system which include heart and vascular system. The global cardiovascular drugs market was valued approximately US$ 80.0 Bn in 2016 and is anticipated to register CAGR of over 1.0% from 2017 to 2025 to reach value of approximately US$ 91.0 Bn by 2025. Drug classes used to treat cardiovascular indications such as hyperlipidemia, hypertension are likely to fuel expansion of the global ... Read more
The cardiovascular drugs market consists of sales of cardiovascular drugs and related services by entities (organizations, sole traders and partnerships) that produce cardiovascular drugs to treat cardiovascular diseases. This industry includes establishments that produce anti-hypertensive drugs to prevent heart failure by controlling blood pressure and hypolipidemic drugs that reduce lipid and lipoprotein levels in the blood. It also consists of establishments which produce antithrombotic ... Read more
The global cardiovascular drugs market rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for cardiovascular drugs are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the cardiovascular drugs market that is critical for ... Read more
TMR’s report on the cardiovascular drugs market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services.
Our research report on the cardiovascular drugs market serves as a valuable guide for market stakeholders. The report deep dives ... Read more
TheBusinessResearchCompany published its Cardiovascular Drugs Global Market Report 2019 which provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs market. The report covers the cardiovascular drugs market’s segments- anti-hypertensive drugs, hypolipidemics, anti thrombotics, other drugs for cardiovascular diseases (congestive heart failure, anti-arrhythmic and anti-anginal drugs).
The demand within the global cardiovascular drugs market is expected to rise in the years to follow. The aforementioned projection is based on the rising incidence of heart diseases, strokes, and cardiac arrests. The field of cardiology has become the cynosure of the healthcare industry, and regional governments have made heavy investments in this sector. Furthermore, the sedentary lifestyles of the ... Read more
TheBusinessResearchCompany published its Cardiovascular Drugs Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs market. The report covers the cardiovascular drugs market’s segments- anti-hypertensive drugs, hypolipidemics, anti thrombotics, other drugs for cardiovascular diseases (congestive heart failure, anti-arrhythmic and anti-anginal drugs).
